These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 11973921

  • 1. [New drugs for the treatment of obesity].
    Mustajoki P.
    Duodecim; 1999; 115(20):2191, 2193-4. PubMed ID: 11973921
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The new role of pharmacotherapy for weight reduction in obesity.
    Fernstrom MH, Fernstrom JD.
    Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983
    [Abstract] [Full Text] [Related]

  • 7. Long-term pharmacotherapy for obesity.
    Klein S.
    Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
    [Abstract] [Full Text] [Related]

  • 8. [Overweight patient has tried many times to lose weight. What helps against stubborn fat padding?].
    Wirth A.
    MMW Fortschr Med; 2003 Mar 06; 145(10):16. PubMed ID: 12688021
    [No Abstract] [Full Text] [Related]

  • 9. Prevention and management of obesity: pharmacology .
    Finer N.
    Proc Nutr Soc; 2000 Aug 06; 59(3):413. PubMed ID: 10997657
    [No Abstract] [Full Text] [Related]

  • 10. [No progress without the physician in therapy of obesity].
    Schmidt H, Plauth M.
    MMW Fortschr Med; 2000 Jan 27; 142(4):35-6. PubMed ID: 10850095
    [No Abstract] [Full Text] [Related]

  • 11. Long-term medication use and weight loss maintenance: an observational study.
    Womble LG, Wadden TA, Berkowitz RI, Sarwer DB, Rothman RA.
    Obes Res; 2001 Oct 27; 9(10):652-3. PubMed ID: 11595785
    [No Abstract] [Full Text] [Related]

  • 12. Orlistat for obesity.
    Med Lett Drugs Ther; 1999 Jun 18; 41(1055):55-6. PubMed ID: 10436767
    [No Abstract] [Full Text] [Related]

  • 13. [A drug help in reducing? Risk profile decides whether and how].
    Hauner H.
    MMW Fortschr Med; 2003 May 22; 145(21):60. PubMed ID: 12845877
    [No Abstract] [Full Text] [Related]

  • 14. [Struggle about the best reducing diet, Fat gone by means of more fat?].
    Bischoff A.
    MMW Fortschr Med; 2004 Jan 15; 146(1-2):4-6. PubMed ID: 18441569
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacologic agents for the treatment of obesity.
    Mathys M.
    Clin Geriatr Med; 2005 Nov 15; 21(4):735-46, vii. PubMed ID: 16182086
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological treatments for obesity.
    McLoughlin C.
    Prof Nurse; 2005 Apr 15; 20(8):50-1. PubMed ID: 15819320
    [Abstract] [Full Text] [Related]

  • 17. Orlistat and sibutramine beyond weight loss.
    Mannucci E, Dicembrini I, Rotella F, Rotella CM.
    Nutr Metab Cardiovasc Dis; 2008 Jun 15; 18(5):342-8. PubMed ID: 17928208
    [Abstract] [Full Text] [Related]

  • 18. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
    Elfhag K, Finer N, Rössner S.
    Diabetes Obes Metab; 2008 Jun 15; 10(6):498-505. PubMed ID: 17593239
    [Abstract] [Full Text] [Related]

  • 19. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.
    Scheen AJ, Ernest P.
    Diabetes Metab; 2002 Dec 15; 28(6 Pt 1):437-45. PubMed ID: 12522323
    [Abstract] [Full Text] [Related]

  • 20. Pharmacologic therapies for obesity.
    Kaplan LM.
    Gastroenterol Clin North Am; 2010 Mar 15; 39(1):69-79. PubMed ID: 20202580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.